share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tatsis Ourania

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tatsis Ourania

福泰製藥 | 4：持股變動聲明-高管 Tatsis Ourania
美股sec公告 ·  06/03 16:12
Moomoo AI 已提取核心訊息
Ourania Tatsis, EVP, Chief Regulatory & Quality Officer at Vertex Pharmaceuticals Inc. (VRTX), completed the sale of company shares on two separate occasions. On May 30, 2024, Tatsis sold 2,350 shares of common stock at a price of $439.11 per share. The following day, on May 31, 2024, an additional 2,250 shares were sold at $445.00 per share. The total number of shares disposed of across both transactions was 4,600, resulting in a combined market value of $2,033,158.50. After these transactions, Tatsis directly holds 51,273 shares of Vertex Pharmaceuticals.
Ourania Tatsis, EVP, Chief Regulatory & Quality Officer at Vertex Pharmaceuticals Inc. (VRTX), completed the sale of company shares on two separate occasions. On May 30, 2024, Tatsis sold 2,350 shares of common stock at a price of $439.11 per share. The following day, on May 31, 2024, an additional 2,250 shares were sold at $445.00 per share. The total number of shares disposed of across both transactions was 4,600, resulting in a combined market value of $2,033,158.50. After these transactions, Tatsis directly holds 51,273 shares of Vertex Pharmaceuticals.
福泰製藥公司（VRTX）執行長法規及品質總裁Ourania Tatsis 在兩次不同的場合完成公司股票賣出。2024年5月30日，Tatsis以每股439.11美元的價格賣出2,350股普通股。翌日，2024年5月31日，另外2,250股以每股445.00美元的價格出售。兩筆交易中出售的股份總數為4,600股，其合併市值為2,033,158.50美元。在這些交易之後，Tatsis 直接持有Vertex Pharmaceuticals的51,273股股票。
福泰製藥公司（VRTX）執行長法規及品質總裁Ourania Tatsis 在兩次不同的場合完成公司股票賣出。2024年5月30日，Tatsis以每股439.11美元的價格賣出2,350股普通股。翌日，2024年5月31日，另外2,250股以每股445.00美元的價格出售。兩筆交易中出售的股份總數為4,600股，其合併市值為2,033,158.50美元。在這些交易之後，Tatsis 直接持有Vertex Pharmaceuticals的51,273股股票。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息